RGC
Regencell Bioscience·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Movement Reasons
Regencell Bioscience Holdings Limited (RGC) Stock Drops in Thin Post-Christmas Trading as DOJ Probe and “Going Concern” Warning Keep Risk Front and Center
- The broader U.S. market was experiencing subdued post-holiday volume on December 26, 2025, which is typical for a low-staffed period around year-end. However, Regencell Bioscience Holdings Limited (RGC) deviated significantly from this trend, dropping by 13.98% on the day.
Ongoing Legal Uncertainties
- In October 2025, Regencell disclosed that it had received a subpoena from the U.S. Department of Justice related to an investigation into its ordinary shares. This subpoena indicated that the DOJ was seeking documents and communications regarding operational, financial, and accounting matters. Regencell anticipated significant legal costs and acknowledged the potential for fines or penalties.
Company’s Acknowledgment of Volatility Without a Matching Fundamental Change
- Regencell has consistently warned investors about its extreme price and volume fluctuations, which can be disconnected from operating performance. This history of volatility, coupled with the DOJ investigation, may have contributed to the sell-off in RGC’s stock.
Discover more stocks
The above data and information are generated by AI and are for reference only. They do not constitute any investment advice.
